{
    "code": "52026703",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026703",
    "time": "2020-10-09 12:33:31",
    "許可證字號": "衛部藥輸字第026703號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/12\/16",
    "發證日期": "104\/12\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202670300",
    "中文品名": "&quot;卡比&quot;伐菌定乾粉注射劑2公克",
    "英文品名": "Ceftazidime Kabi 2g, Powder for Solution for injection or infusion",
    "適應症": "Ceftazidime是殺菌性頭孢子菌抗生素、對多種乙內醯胺酶有抵抗力、並對廣範圍的革蘭氏陽性及陰性細菌有效。",
    "劑型": "240乾粉注射劑",
    "包裝": "2公克玻璃瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CEFTAZIDIME 5H2O",
    "限制項目": "02輸　入",
    "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
    "申請商地址": "台北市大安區仁愛路三段30號5樓32號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FPT0017000  LABESFAL, LABORATORIOS ALMIRO, S.A.",
            "製造廠廠址": "ZONA INDUSTRIAL DO LAGEDO, 3465-157 SANTIAGO DE BESTEIROS, PORTUGAL",
            "製造廠公司地址": "",
            "製造廠國別": "PORTUGAL",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812302305",
            "成分名稱": "CEFTAZIDIME 5H2O",
            "含量描述": "Ceftazidime pentahydrate (corresponding to 2000mg Ceftazidime)",
            "含量": "2329.6000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "伐菌定乾粉注射劑-仿單320x340mm-105-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026703&Seq=001&Type=9"
        },
        {
            "title": "伐菌定乾粉注射劑-2g瓶標50ml-105-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026703&Seq=002&Type=8"
        }
    ]
}